Ruby Yun‐Ju Huang

National University of Singapore — Singapore

Medicine · Health Sciences

44h-index23.6kcitations190works5.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(43), Ovarian cancer diagnosis and treatment(39), Cancer-related molecular mechanisms research(28), RNA modifications and cancer(16), Cancer Genomics and Diagnostics(13)

Publications189 total

Mapping the plasma proteomic architecture of systemic lupus erythematosus
2025Open Access
Grainyhead-Like 2 Expression Is Associated with Disease Progression, Chemoresistance and Poor Survival in Tubo-Ovarian High-Grade Serous Carcinoma
Pathobiology·2025Open Access
Deep Spatial Transcriptomic Profiling of Ovarian Clear Cell Carcinoma in the Real-World Setting
2025Open Access
Carcinomas exhibiting epithelial–mesenchymal transition manifest an M2 macrophage-enriched tumor immune microenvironment
Breast Cancer Research·2025· 1 citedOpen Access
Morphogenetic maturation of chicken chorioallantoic membrane (CAM) and its disruption by tumor xenografts
Developmental Biology·2025· 1 cited
Epithelial-mesenchymal transition
Cell·2025· 13 citedOpen Access
Proximity and metabolic activity proxies in the tumor microenvironment as predictors of survival in high grade serous ovarian cancer
iScience·2025Open Access
EMT and cancer: what clinicians should know
Nature Reviews Clinical Oncology·2025· 15 citedOpen Access
Abstract 2750: Alternative enhancer usage of <i>PER2</i> locus regulating 3D genome architecture in epithelial-mesenchymal states
Cancer Research·2025
Proximity and metabolic activity of the Tumour Microenvironment as predictors of survival in High Grade Serous Ovarian Cancer (HGSOC)
2025Open Access
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Journal of Hematology & Oncology·2025· 93 citedOpen Access
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)
Journal of Gynecologic Oncology·2024· 7 citedOpen Access
SPATIAL TRANSCRIPTOMIC PROFILING OF ADVANCED OVARIAN CLEAR CELL CARCINOMA REVEALS INTRA-TUMOR HETEROGENEITY IN EPITHELIAL-MESENCHYMAL GRADIENT
2024· 1 citedOpen Access
Loss of PERIOD2 (PER2) induces HO-1-mediated epithelial-mesenchymal transition and cisplatin resistance in Epi-A ovarian cancer
2024· 1 citedOpen Access
Immunological impact of intraperitoneal and intravenous chemotherapy in ovarian cancer, translational analyses of the Phase 3 iPocc trial
Gynecologic Oncology·2024· 1 cited
Spatial Profiling of Ovarian Clear Cell Carcinoma Reveals Immune-Hot Features
Modern Pathology·2024· 7 citedOpen Access
PR056/#319  High frequencies of fusion transcripts (FT) identified in ovarian clear cell carcinoma (OCCC) by comprehensive genomic profiling (CGP)
2024
Ovarian Clear Cell Carcinoma: An Endometriosis-Associated Cancer with Therapeutic Challenges
Cold Spring Harbor Perspectives in Medicine·2024· 2 citedOpen Access
Inter- and intra-tumor heterogeneous immune presentation in primary uterine carcinosarcoma determined by digital spatial profiling
2024Open Access
Regulating epithelial-mesenchymal plasticity from 3D genome organization
Communications Biology·2024· 6 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Jean Paul Thiery(23), Tuan Zea Tan(22), Jieru Ye(8), M. K. Wong(6), Vin Yee Chung(6), Mahesh Choolani(6), Seiichi Mori(5), Gautam Sethi(5), Alan Prem Kumar(5), Kuee Theng Kuay(4), Jeffrey Low(4), Jane Antony(4), Asad Mohammad(4), M. Ángela Nieto(3), Mei Shan Ong(3), Frank Arfuso(3), Celestial T. Yap(3), Boon Cher Goh(3), Noriomi Matsumura(3), Rebecca Jackson(2)